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Abstract
Background: Aside from the skeletal health affection, vitamin D deficiency has been implicated as a potential
environmental factor triggering for some autoimmune disorders. Vitamin D might play a role in the regulation of
the production of auto-antibodies. Immunomodulatory effects of vitamin D may act not only through modulation
of T-helper cell function, but also through induction of CD4+CD25high regulatory T-cells. We are the first to
investigate the relationship between serum levels of 25-hydroxy vitamin D and anti-myelin-associated glycoprotein
(anti-MAG) auto-antibodies in autistic children.
Methods: Serum levels of 25-hydroxy vitamin D and anti-MAG auto-antibodies were measured in 50 autistic
children, aged between 5 and 12 years, and 30 healthy-matched children. Serum 25-hydroxy vitamin D levels
10–30 ng/mL and < 10 ng/mL were defined as vitamin D insufficiency and deficiency, respectively.
Results: Autistic children had significantly lower serum levels of 25-hydroxy vitamin D than healthy children
(P< 0.001) with 40% and 48% being vitamin D deficient and insufficient, respectively. Serum 25-hydroxy vitamin D
had significant negative correlations with Childhood Autism Rating Scale (P< 0.001). Increased levels of serum
anti-MAG auto-antibodies were found in 70% of autistic patients. Serum 25-hydroxy vitamin D levels had significant
negative correlations with serum levels of anti-MAG auto-antibodies (P< 0.001).
Conclusions: Vitamin D deficiency was found in some autistic children and this deficiency may contribute to the
induction of the production of serum anti-MAG auto-antibodies in these children. However, future studies looking
at a potential role of vitamin D in the pathophysiology and treatment of autism are warranted.
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Background
Vitamin D is the common denominator of a group of
sterols with a crucial role in calcium and phosphorus
metabolism. The main source of vitamin D is the con-
version of 7-dehydrocholesterol to pre-vitamin D3 in the
skin, by means of solar ultraviolet B radiation, and a
lesser amount of vitamin D is obtained from food. Vita-
min D3 undergoes a 25-hydroxylation in the liver, with
the resulting product, 25-hydroxy vitamin D or calcidiol,
being the main circulating form of vitamin D. Therefor,
25-hydroxy vitamin D levels are used to determine the
vitamin D status of a given individual [1,2]. The fully ac-
tive form 1, 25 dihydroxy vitamin D3, is synthesized in
the kidneys by the 25-hydroxy vitamin D-1a hydroxylase,
an enzyme which is mainly induced by the parathyroid
hormone (PTH). The main metabolic effect of 1, 25
dihydroxy vitamin D3, which is mediated through the
interaction with vitamin D receptors, is promoting the
intestinal absorption and renal resorption of calcium in
order to increase its circulating levels. Deficient levels of
vitamin D promote PTH synthesis that results in bone
resorption. Long-lasting depletion of vitamin D causes
rickets and osteomalacia, with skeletal deformities in
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children and bone pain and increased risk of fractures in
adults, respectively [3].
A role for vitamin D in the regulation of immune
function was first proposed after the identification of
vitamin D receptors in lymphocytes. It has since been
recognized that the active form of vitamin D has direct
affects on naïve and activated helper T cells, regulatory
T cells, activated B cells, and dendritic cells. There is a
growing body of literature linking vitamin D to various
immune-related conditions, including allergy and auto-
immunity [4]. Recently, vitamin D deficiency has been
implicated as a potential environmental factor triggering
some autoimmune disorders, including multiple sclerosis
(MS) and systemic lupus erythematosus (SLE) [5-7].
Autoimmunity may have a role in the pathogenesis of
autism in a subgroup of patients. This may be indicated
by the presence of brain-specific auto-antibodies in
some autistic children [8-15]. There is also an increase
in the frequency of autoimmune disorders among autis-
tic families [16-22].
This study was the first to investigate the relationship
between serum levels of 25-hydroxy vitamin D and anti-
MAG auto-antibodies, as indicators of autoimmunity to
brain tissue, in a group of autistic children.
Methods
Study population
This cross-sectional study was conducted on 50 children
with autism. They were recruited from the Autism Re-
search and Treatment Center, Faculty of Medicine, King
Saud University, Riyadh, Saudi Arabia. Patients were ful-
filling the criteria of the diagnosis of autism according to
the fourth edition of the Diagnostic and Statistical Man-
ual of Mental Disorders [23]. The autistic group com-
prised 39 boys and 11 girls. Their ages ranged between 5
and 12 years (mean ± SD= 8.24 ± 2.37 years). Patients
who had associated neurological diseases (such as cere-
bral palsy and tuberous sclerosis) and metabolic disor-
ders (for example, phenylketonuria) were excluded from
the study. Also, autistic patients on casein-free diet were
not included.
The control group comprised 30 age- and sex-matched
apparently healthy children. They included twenty-four
boys and six girls. They were the healthy older siblings of
the healthy infants who attend the Well Baby Clinic, King
Khalid University Hospital, Faculty of Medicine, King
Saud University, Riyadh, Saudi Arabia for routine follow-
up of their growth parameters. The control children were
not related to the children with autism, and demonstrated
no clinical findings suggestive of immunological or neuro-
psychiatric disorders. Their ages ranged between 5 and
12 years (mean±SD=8.63± 2.65 years).
All studied subjects had normal body weight (body mass
index (BMI) was between the fifth and less than the 85th
percentiles based on age and sex). In addition, all subjects
were studied during summer (April to September) to
avoid the effect of seasonal variation on serum 25 hydroxy
vitamin D levels. Hours of sun exposure per week were
recorded for all studied subjects. All studied children had
not received calcium and/or vitamin D therapy in the
past 6 months. In addition, none of them had a concomi-
tant infection, photosensitivity, used photoprotection
(such as broad-spectrum sunscreens) or treatment known
to affect serum 25 hydroxy vitamin D levels (such as anti-
epileptic drugs, corticosteroids, and other immunosup-
pressive drugs).
The local Ethical Committee of the Faculty of Medi-
cine, King Saud University, Riyadh, Saudi Arabia,
approved this study. In addition, an informed written
consent of participation in the study was signed by the
parents or the legal guardians of the studied subjects.
Study measurements
Clinical evaluation of autistic patients
This was based on clinical history taking from caregivers,
clinical examination, and neuropsychiatric assessment. In
addition, the degree of the disease severity was assessed
by using the Childhood Autism Rating Scale (CARS) [24]
which rates the child on a scale from 1 to 4 in each of 15
areas (relating to people; emotional response; imitation;
body use; object use; listening response; fear or nervous-
ness; verbal communication; non-verbal communication;
activity level; level and consistency of intellectual re-
sponse; adaptation to change; visual response; taste, smell
and touch response; and general impressions). According
to the scale, children who have scored 30 to 36 have mild
to moderate autism (n=18), while those with scores ran-
ging between 37 and 60 points have a severe degree of
autism (n=32).
Assay of serum 25-hydroxy vitamin D
This assay employs by enzyme-linked immunosorbent
assay using a competitive protein binding assay kit for
the measurement of 25-hydroxy vitamin D, which is
based on the competition of 25-hydroxy vitamin D
present in the sample with 25-hydroxy vitamin D tracer,
for the binding pocket of vitamin D protein (VDBP, Gc-
globulin). According to current recommendations,
serum 25-hydroxy vitamin D levels < 30 and < 10 ng/mL
were defined as vitamin D insufficiency and vitamin D
deficiency, respectively, while levels > 30 ng/mL were
defined as vitamin D sufficiency [25].
Assessment of serum anti-myelin associated glycoprotein
(anti-MAG) antibodies
This assay employs the quantitative sandwich-type en-
zyme immunoassay (EIA) technique (Buhlmann Labora-
tories AG, Baselstrasse 55, CH-4124 Schonenbuch,
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Switzerland). Highly purified MAG from human brain
has been precoated into a microtiter plate. Calibrators
and patient sera were incubated for in the microtiter
wells and any anti-MAG auto-antibodies present were
bound by the immobilized human MAG. After washing
away any unbound substances, horseradish peroxidase
labeled antibodies against human IgM were added to the
wells and incubated. After a wash step, the substrate so-
lution containing tetramethylbenzidin was added. The
color developed in proportion to the amount of anti-
MAG antibodies bound in the initial step was stopped
by adding an acidic stop solution. The intensity of the
color absorbance was measured in a microtiter plate
reader at a wavelength of 450 nm. To increase accuracy,
all samples were analyzed twice in two independent
experiments to assess the interassay variations and to
ensure reproducibility of the observed results (P > 0.05).
No significant cross-reactivity or interference was
observed.
Statistical analyses
The results were analyzed by the commercially available
software package (Statview, Abacus concepts, Inc., Berkley,
CA, USA). The parametric data were presented as mean
and standard deviation (SD). In addition, non-parametric
data were presented as median and interquartile range
(IQR), which is the difference between the 75th and 25th
percentiles. Students t-test was used for comparison of
parametric data, while Mann–Whitney U-test was used for
comparison of non-parametric data. Chi-square test was
used for comparison between qualitative variables of the
studied groups. Spearman’s rho correlation coefficient ‘r’
was used to determine the relationship between different
variables. For all tests, a probability (P) of <0.05 was consid-
ered significant. Two SD above the mean value of serum
anti-MAG auto-antibodies of healthy controls, 1983.45
Buhlmann titre unit (BTU), were considered to be elevated
in autistic patients.
Results
Serum levels of 25-hydroxy vitamin D in autistic patients
and healthy children
Autistic children had significantly lower serum levels of
25-hydroxy vitamin D (median (IQR) = 18.5 (14) ng/mL)
than healthy children (median (IQR) = 33 (11) ng/mL),
P < 0.001 (Figure 1), with 40% and 48% being vitamin D
deficient and insufficient, respectively. None of the
healthy children was vitamin D deficient, but 20% were
vitamin D insufficient (Table 1).
Serum 25-hydroxy vitamin D had significant negative
correlations with CARS (r =−0.84, P < 0.001). Although
patients with severe autism had lower serum 25-hydroxy
vitamin D than children with mild to moderate autism,
this difference did not reach statistical significance,
P= 0.06 (Table 2). Serum 25-hydroxy vitamin D had no
significant correlations with the age of autistic children
(P= 0.83). In addition, there was no significant difference
between male and female autistic children in serum
levels of 25-hydroxy vitamin D (P > 0.05).
There was no significant difference between autistic
children and healthy children in the duration of sun ex-
posure/week (P= 0.49). In addition, serum 25-hydroxy
vitamin D had no significant correlations with the dur-
ation of sun exposure/week (P= 0.96).
Serum levels of anti-MAG auto-antibodies in autistic
patients and healthy children
Autistic children had significantly higher serum levels
of anti-MAG auto-antibodies (2274.22 ± 578.32 BTU)

















z = 6.17, p < 0.001
Figure 1 Serum levels of 25-hydroxy vitamin D in the studied
children. The boxes enclose the interquartile range (IQR), which are
between the 25th and 75th percentiles. The horizontal line inside
the box represents the median and the whiskers represent the
non-outlier (between 1.5 and 3 IQR) or extreme (more than 3 IQR)
maximum and minimum values of serum 25-hydroxy vitamin D.
Table 1 Basic clinical data and vitamin D status of the
studied children




Age ( years) 8.24 ± 2.37 8.63 ± 2.65
Sex (male/female) 39/11 24/6
The duration of sun
exposure (hours/week)





(10 to 30 ng/mL)
48% (24/50) 20% (6/30)
Vitamin D sufficiency
(>30 ng/mL)
12% (6/50) 80% (24/30)
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(Figure 2). According to the highest cut-off values of
serum anti-MAG auto-antibodies, increased levels were
found in 70% of autistic patients.
Patients with severe autism had significantly higher
serum anti-MAG auto-antibodies than children with mild
to moderate autism, P < 0.001 (Table 2). In addition, chil-
dren with severe autism had significantly higher frequency
of seropositivity of anti-MAG auto-antibodies (90.6%)
than autistic patients with mild to moderate autism
(33.3%), P < 0.001. Also, serum anti-MAG auto-antibodies
had significant positive correlations with CARS (r = 0.81,
P < 0.001). In contrast, serum anti-MAG auto-antibodies
had no significant correlations with the age of autistic
children (P= 0.5).
The relationship between serum levels of 25-hydroxy
vitamin D and anti-MAG auto-antibodies in autistic
children
Serum 25-hydroxy vitamin D levels had significant nega-
tive correlations with serum levels of anti-MAG auto-
antibodies (P < 0.001), Figure 3.
Discussion
Immune abnormalities, mainly autoimmunity to brain
tissue, may have a pathogenic role in autism [26-29]. Re-
cently, vitamin D deficiency has been implicated as a
potential environmental factor triggering some auto-
immune disorders [5,6].
In the present study, autistic children had significantly
lower serum levels of 25-hydroxy vitamin D than healthy
children, P < 0.001, with 40% and 48% being vitamin D
deficient and insufficient, respectively.
Vitamin D deficiency is being associated with a num-
ber of psychiatric conditions with a developmental basis,
such as autism and schizophrenia. Vitamin D deficiency
in early life affects neuronal differentiation, axonal con-
nectivity, dopamine ontogeny, and brain structure and
function [30]. Some investigators reported reduced
serum 25-hydrox vitamin D in autistic children. These
studies could classify them as being ‘vitamin D inad-
equate’, which lends support to the hypothesis that aut-
ism is a vitamin D deficiency disorder [31,32].
Worldwide, the rate of autism has been steadily rising.
There are several environmental factors in concert with
genetic susceptibilities that are contributing to this rise.
Genetic polymorphisms of cytochrome P450 enzymes
have also been linked to autism, specifically CYP27B1
that is essential for proper vitamin D metabolism. Three
novel structural variants of the vitamin D receptor were
reported in psychiatric disease [33]. Further study is
required to clarify their role, if any, in autism.
Table 2 Serum levels of 25-hydroxy vitamin D and anti-MAG auto-antibodies in relation to the severity of autism





Serum 25-hydroxy vitamin D
(ng/mL) (median (IQR))
20.5 (16) 14.5 (15) 1.82 (0.06)
Serum anti-MAG
(BTU) (mean± SD)
1827.5 ± 349.9 2525.5 ± 529.6 5.6 (<0.001)






















t = 7.1, p < 0.001
Figure 2 Serum levels of anti-MAG auto-antibodies in the
studied children. Anti-MAG, anti-myelin-associated glycoprotein
antibodies; BTU, Buhlmann titre unit.
3530252015105


















r = - 0.86, p < 0.001
Figure 3 Negative correlations between serum levels of
25-hydroxy vitamin D and anti-MAG auto-antibodies in
children with autism. Anti-MAG, anti-myelin-associated
glycoprotein antibodies; BTU, Buhlmann titre unit.
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In the present work, serum 25-hydroxy vitamin D
levels had significant negative correlations with CARS
(P < 0.001) which signifies the possible link between the
extent of vitamin D deficiency and the degree of the se-
verity of autism. Vitamin D receptors and vitamin D me-
tabolizing enzymes are present in CNS. Calcitriol, the
active vitamin D, affects numerous neurotransmitters
and neurotrophic factors, relevant for mental disorders
[34]. In addition, vitamin D plays important roles in
repairing DNA damage and protecting against oxidative
stress which is a key cause of DNA damage. Thus, vita-
min D deficiency may contribute to higher mutation
rates and impaired repair of DNA [35] as a result of
increased oxidative stress which was reported in some
autistic children [22]. In addition, Calcitriol may down-
regulate the production of inflammatory cytokines in the
brain that have been suggested to be associated with aut-
ism [36].
Maternal vitamin D deficiency may be a risk factor for
autism, possibly by affecting fetal brain development as
well as by affecting maternal immune system status dur-
ing pregnancy [37,38]. Autism was more common
among children of the mothers who took antiepileptic
drugs as these drugs are one of the few classes of drugs
that consistently and significantly interfere with vitamin
D metabolism [39]. Unfortunately, the tiny 10 μg
(400 IU) dose in prenatal vitamins is virtually irrelevant
in preventing gestational vitamin D deficiency [40]. For
this reason, in 2007, the Canadian Paediatric Society
recommended 2000 IU/day, or more, to prevent gesta-
tional vitamin D deficiency [25].
The current study revealed no significant difference
between autistic children and healthy children in the
duration of sun exposure/week (P= 0.49). In addition,
serum 25-hydroxy vitamin D had no significant correla-
tions with the duration of sun exposure/week in children
with autism (P= 0.96). In addition, all subjects were
studied during summer (April to September) to avoid
the effect of seasonal variation on serum 25 hydroxy
vitamin D levels. Thus, the results of our study did not
signify the reduced duration of sun exposure as a causal
factor of 25 hydroxy vitamin D deficiency in autistic
children.
In this study, autistic children had significantly higher
serum levels of anti-MAG auto-antibodies than healthy
children, P < 0.001. Increased serum levels of anti-MAG
auto-antibodies were found in 70% of autistic patients. A
previous study conducted on 32 Egyptian children, aged
between 3 and 8 years, reported anti-MAG seropositivity
in 62.5% of autistic children [10]. MAG is a minor mye-
lin protein that is located in the most periaxonal oligo-
dendrocytes processes. It controls neurofilament
phosphorylation and hence, controls the axon caliber
which is crucial for efficient impulse transmission. In
contrast to mature CNS, MAG promotes regeneration
of young neurons [41]. Circulating anti-MAG antibodies
may play an etiopathogenic role in some autoimmune
disorders as autoimmune chronic demyelinating neur-
opathy [42]. Autoimmune reaction to neurons might be
initiated by environment triggers resulting in the release
of neuronal antigens, which through the activation of in-
flammatory cells, may result in autoimmune reactions in
genetically susceptible individuals [26,27].
In the present work, patients with severe autism had
significantly higher serum anti-MAG auto-antibodies
than children with mild to moderate autism, P < 0.001.
Also, serum anti-MAG auto-antibodies had significant
positive correlations with CARS (P < 0.001). These
results may indicate that the extent of the elevation of
serum anti-MAG auto-antibodies was possibly linked to
the degree of the disease severity assessed by CARS.
Thus, anti-MAG auto-antibodies might be playing a role
in the pathogenesis of brain damage, the extent of which
may determine the clinical severity of autism.
Vitamin D deficiency has been implicated as a potential
environmental factor triggering some autoimmune disor-
ders suggesting that vitamin D might play a role in regu-
lating auto-antibody production [5,6]. In this study, we
have tried to find a possible link between the reduced
serum levels of 25-hydroxy vitamin D and the elevated
serum levels of anti-MAG auto-antibodies in autism.
Serum 25-hydroxy vitamin D levels had significant nega-
tive correlations with serum levels of anti-MAG auto-
antibodies (P < 0.001). We could not trace data in the
literature concerning the possible contributing role of
25-hydroxy vitamin D deficiency in the induction of the
production of brain-specific auto-antibodies in some aut-
istic children to compare our results. We are the first to
study such a relationship.
In animal models, an increased Th2 response to vita-
min D has been accompanied by increase in anti-
inflammatory IL-10 response [43]. Immunomodulatory
effect of vitamin D may act not only through modulation
of helper T cell function, but also through induction of
CD4+CD25high regulatory T-cells (Tregs) [44]. CD4
+CD25high regulatory T-cells play an important role in
the establishment of the immunological self tolerance
and thereby, preventing autoimmunity [45]. Tregs can
suppress Th17 cells, the key players in the pathogenesis
of autoimmune disorders, and autoimmunity [46]. A re-
cent study reported deficiency of Tregs in 73.3% of aut-
istic children [21]. Thus, vitamin D deficiency may be a
contributing factor to the production of brain-specific
auto-antibodies as a result of deficiency of Tregs in some
autistic children.
The results of this study may indicate that 25-hydroxy
vitamin D deficiency may be a possible contributing
factor to the increased frequency of serum anti-MAG
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auto-antibodies in some autistic children. However, this
is an initial report that warrants further research to de-
termine the possible link between 25-hydroxy vitamin D
deficiency and the increased frequency of brain-specific
auto-antibodies in some children with autism.
The vitamin D theory of autism does not diminish
genetic contributions to autism occurrence. Indeed,
without the genetic tendency for autism, severe maternal
or early childhood vitamin D deficiency may cause bone
abnormalities with no evidence autism. Maternal and
early childhood vitamin D deficiency may allow the gen-
etic tendency for autism to express itself. If this theory is
true, the path towards effective prevention and perhaps
a treatment is so simple, so safe, so inexpensive, so read-
ily available and so easy [47]. Basic, genetic, and epi-
demiological studies indicate a potential role of vitamin
D in the prevention of autoimmune diseases, but rando-
mized and controlled trials are necessary to establish the
clinical efficacy of vitamin D supplementation in ill or
at-risk subjects [48]. Three treatment modalities exist
for vitamin D deficiency which include; sunlight, artifi-
cial ultraviolet B radiation, and vitamin D3 supplementa-
tion. Treatment of vitamin D deficiency in patients with
2,000 to 7,000 IU vitamin D per day should be sufficient
to maintain year-round levels between 40 and 70 ng/mL
[49]. Children with chronic illnesses such as autism, dia-
betes, and/or frequent infections should be supplemen-
ted with higher doses of sunshine or vitamin D3 [47].
Conclusions
Vitamin D deficiency was found in some autistic chil-
dren and this deficiency may contribute to the induction
of the production of serum anti-MAG auto-antibodies
in these children. However, future studies looking at a
potential role of vitamin D in the pathophysiology and
treatment of autism are warranted.
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